TY - JOUR
T1 - Heterozygous HMGB1 loss-of-function variants are associated with developmental delay and microcephaly
AU - Uguen, Kévin
AU - Krysiak, Kilannin
AU - Audebert-Bellanger, Séverine
AU - Redon, Sylvia
AU - Benech, Caroline
AU - Viora-Dupont, Eléonore
AU - Tran Mau-Them, Frederic
AU - Rondeau, Sophie
AU - Elsharkawi, Ibrahim
AU - Granadillo, Jorge L.
AU - Neidich, Julie
AU - Soares, Celia Azevedo
AU - Tkachenko, Natáliya
AU - M. Amudhavalli, Shivarajan
AU - Engleman, Kendra
AU - Boland, Anne
AU - Deleuze, Jean François
AU - Bezieau, Stéphane
AU - Odent, Sylvie
AU - Toutain, Annick
AU - Bonneau, Dominique
AU - Gilbert-Dussardier, Brigitte
AU - Faivre, Laurence
AU - Rio, Marlène
AU - Le Marechal, Cedric
AU - Ferec, Claude
AU - Repnikova, Elena
AU - Cao, Yang
N1 - Publisher Copyright:
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
PY - 2021/10
Y1 - 2021/10
N2 - 13q12.3 microdeletion syndrome is a rare cause of syndromic intellectual disability. Identification and genetic characterization of patients with 13q12.3 microdeletion syndrome continues to expand the phenotypic spectrum associated with it. Previous studies identified four genes within the approximately 300 Kb minimal critical region including two candidate protein coding genes: KATNAL1 and HMGB1. To date, no patients carrying a sequence-level variant or a single gene deletion in HMGB1 or KATNAL1 have been described. Here we report six patients with loss-of-function variants involving HMGB1 and who had phenotypic features similar to the previously described 13q12.3 microdeletion syndrome cases. Common features included developmental delay, language delay, microcephaly, obesity and dysmorphic features. In silico analyses suggest that HMGB1 is likely to be intolerant to loss-of-function, and previous in vitro data are in line with the role of HMGB1 in neurodevelopment. These results strongly suggest that haploinsufficiency of the HMGB1 gene may play a critical role in the pathogenesis of the 13q12.3 microdeletion syndrome.
AB - 13q12.3 microdeletion syndrome is a rare cause of syndromic intellectual disability. Identification and genetic characterization of patients with 13q12.3 microdeletion syndrome continues to expand the phenotypic spectrum associated with it. Previous studies identified four genes within the approximately 300 Kb minimal critical region including two candidate protein coding genes: KATNAL1 and HMGB1. To date, no patients carrying a sequence-level variant or a single gene deletion in HMGB1 or KATNAL1 have been described. Here we report six patients with loss-of-function variants involving HMGB1 and who had phenotypic features similar to the previously described 13q12.3 microdeletion syndrome cases. Common features included developmental delay, language delay, microcephaly, obesity and dysmorphic features. In silico analyses suggest that HMGB1 is likely to be intolerant to loss-of-function, and previous in vitro data are in line with the role of HMGB1 in neurodevelopment. These results strongly suggest that haploinsufficiency of the HMGB1 gene may play a critical role in the pathogenesis of the 13q12.3 microdeletion syndrome.
KW - HMGB1
KW - developmental disabilities
KW - dysmorphic features
KW - loss of function mutation
UR - http://www.scopus.com/inward/record.url?scp=85114111824&partnerID=8YFLogxK
U2 - 10.1111/cge.14015
DO - 10.1111/cge.14015
M3 - Article
C2 - 34164801
AN - SCOPUS:85114111824
SN - 0009-9163
VL - 100
SP - 386
EP - 395
JO - Clinical Genetics
JF - Clinical Genetics
IS - 4
ER -